Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotech companies, Nanoscope said.
Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotech companies, Nanoscope said.
"There are over 10,000 rare diseases that affect millions of people worldwide, and most of them are genetic," notes UT Southwestern's Steven Gray (above, with Susan Iannaccone, M.D.). Testing on a total of eight genetic diseases has been approved for funding by the Bespoke Gene Therapy Consortium and other organizations.
Fort Worth-based Range Resources (NYSE: RRC) has agreed to be acquired by Canonsburg, Pennsylvania-based EQT (NYSE: EQT). The $13 billion all-stock deal would bolster EQT’s status as the country’s No. 1 natural gas producer....
Addison-based Firehawk Defense has reached unicorn status, closing a more than $150 million Series D funding round with a valuation of more than $1.4 billion.
Boston-based Advent International and West Palm Beach, Florida-based Rochefort Asset Management were the lead investors....
Fort Worth-based Range Resources (NYSE: RRC) has agreed to be acquired by Canonsburg, Pennsylvania-based EQT (NYSE: EQT). The $13 billion all-stock deal would bolster EQT’s status as the country’s No. 1 natural gas producer....
Addison-based Firehawk Defense has reached unicorn status, closing a more than $150 million Series D funding round with a valuation of more than $1.4 billion.
Boston-based Advent International and West Palm Beach, Florida-based Rochefort Asset Management were the lead investors....